Table 9.
STEMI | NSTEMI | |||||
---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | |||
SHR | ||||||
Below proposed cut-off | 1.00 | Reference | 1.00 | Reference | ||
Above proposed cut-off | 2.20 | 1.73 | 2.79 | 1.25 | 0.90 | 1.75 |
Age in years | ||||||
< 40 | 1.00 | Reference | 1.00 | Reference | ||
40–49 | 1.24 | 0.47 | 3.31 | 0.34 | 0.08 | 1.52 |
50–59 | 1.45 | 0.56 | 3.74 | 0.44 | 0.11 | 1.71 |
60–69 | 2.21 | 0.86 | 5.69 | 0.75 | 0.20 | 2.84 |
70–79 | 3.88 | 1.49 | 10.15 | 1.22 | 0.32 | 4.63 |
≥ 80 | 7.79 | 2.90 | 20.91 | 2.11 | 0.54 | 8.32 |
History of MI/PCI/CABG | ||||||
No | 1.00 | Reference | 1.00 | Reference | ||
Yes | 1.19 | 0.89 | 1.58 | 1.53 | 1.12 | 2.09 |
Killip class on admission | ||||||
I | 1.00 | Reference | 1.00 | Reference | ||
II | 1.49 | 0.96 | 2.32 | 2.85 | 1.94 | 4.20 |
III | 2.46 | 1.65 | 3.66 | 3.20 | 2.08 | 4.93 |
IV | 4.06 | 3.08 | 5.36 | 21.26 | 10.64 | 42.50 |
CPR on arrival | ||||||
No | 1.00 | Reference | 1.00 | Reference | ||
Yes | 3.72 | 2.62 | 5.30 | 10.29 | 3.24 | 32.71 |
Creatinine in µmol/L | ||||||
< 70 | 1.00 | Reference | 1.00 | Reference | ||
70–105 | 0.72 | 0.50 | 1.05 | 0.71 | 0.43 | 1.16 |
106–140 | 1.57 | 1.07 | 2.31 | 1.35 | 0.79 | 2.30 |
141–176 | 2.07 | 1.29 | 3.33 | 1.20 | 0.61 | 2.36 |
177–353 | 2.44 | 1.47 | 4.03 | 1.21 | 0.58 | 2.55 |
≥ 354 | 3.51 | 1.86 | 6.59 | 4.43 | 2.45 | 8.01 |
Haemoglobin in g/dL | ||||||
< 10 | 1.00 | Reference | 1.00 | Reference | ||
10–11 | 1.28 | 0.73 | 2.27 | 1.27 | 0.73 | 2.22 |
12–13 | 0.86 | 0.50 | 1.49 | 1.10 | 0.62 | 1.96 |
14–15 | 0.60 | 0.34 | 1.05 | 0.45 | 0.23 | 0.88 |
≥ 16 | 0.73 | 0.39 | 1.34 | 0.42 | 0.16 | 1.10 |
CABG coronary artery bypass grafting, CI confidence interval, MI myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarction, OR odds ratio, PCI percutaneous coronary intervention, SHR stress-hyperglycaemia ratio, STEMI ST-segment elevation myocardial infarction